The store will not work correctly when cookies are disabled.
(6-fluoro-4-(piperidin-1-yl)quinolin-3-yl)(4-methoxyphenyl)methanone
ID: ALA4578440
PubChem CID: 5640185
Max Phase: Preclinical
Molecular Formula: C22H21FN2O2
Molecular Weight: 364.42
Molecule Type: Unknown
Associated Items:
Names and Identifiers
Canonical SMILES: COc1ccc(C(=O)c2cnc3ccc(F)cc3c2N2CCCCC2)cc1
Standard InChI: InChI=1S/C22H21FN2O2/c1-27-17-8-5-15(6-9-17)22(26)19-14-24-20-10-7-16(23)13-18(20)21(19)25-11-3-2-4-12-25/h5-10,13-14H,2-4,11-12H2,1H3
Standard InChI Key: HBJAOVQVJNRNPY-UHFFFAOYSA-N
Molfile:
RDKit 2D
27 30 0 0 0 0 0 0 0 0999 V2000
14.6457 -17.1942 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.4621 -17.1945 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.8715 -16.4863 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.4585 -15.7762 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.2389 -16.4842 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.6430 -15.7803 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.2377 -15.0823 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.4267 -15.0821 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.0227 -15.7859 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.4296 -16.4900 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.2055 -15.7871 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
14.2357 -17.9011 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
13.4190 -17.8966 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.0092 -18.5994 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.4130 -19.3103 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.2311 -19.3138 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.6455 -18.6065 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.8704 -17.9024 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.4614 -18.6099 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
16.6876 -17.9028 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.0914 -18.6110 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.9079 -18.6117 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.3176 -17.9037 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.9050 -17.1934 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.0899 -17.1962 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.1348 -17.9030 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
19.5440 -18.6104 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5 1 2 0
1 2 1 0
2 3 2 0
3 4 1 0
4 6 2 0
5 6 1 0
5 10 1 0
6 7 1 0
7 8 2 0
8 9 1 0
9 10 2 0
9 11 1 0
1 12 1 0
12 13 1 0
12 17 1 0
13 14 1 0
14 15 1 0
15 16 1 0
16 17 1 0
2 18 1 0
18 19 2 0
18 20 1 0
20 21 2 0
21 22 1 0
22 23 2 0
23 24 1 0
24 25 2 0
25 20 1 0
23 26 1 0
26 27 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 364.42 | Molecular Weight (Monoisotopic): 364.1587 | AlogP: 4.60 | #Rotatable Bonds: 4 |
Polar Surface Area: 42.43 | Molecular Species: NEUTRAL | HBA: 4 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 6.01 | CX LogP: 4.53 | CX LogD: 4.52 |
Aromatic Rings: 3 | Heavy Atoms: 27 | QED Weighted: 0.63 | Np Likeness Score: -1.25 |
References
1. He LJ, Zhu YB, Fan QZ, Miao DD, Zhang SP, Liu XP, Zhang C.. (2019) Shape-based virtual screen for the discovery of novel CDK8 inhibitor chemotypes., 29 (4): [PMID:30630717] [10.1016/j.bmcl.2018.12.065] |